SHIELD THERAPEUTICS
Shield Therapeutics is an independent specialty pharmaceutical company focused on the development and commercialisation of late-stage, mineral-derived hospital pharmaceuticals which address areas of high unmet medical need. During 2011 Shield will be commencing global pivotal Phase III studies of its lead asset, ST10-021, for the treatment of iron deficiency anaemia associated with inflammatory bowel disease and subsequently chronic kidney disease. The Company is headquartered in Wollerau, Switzerland.
SHIELD THERAPEUTICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2008-01-01
Address:
Weybridge, Surrey, United Kingdom
Country:
United Kingdom
Website Url:
http://www.shieldtherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
8.2 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Font Awesome Nginx YouTube Person Schema Gravatar Profiles Typekit Amazon SSL
Current Employees Featured
Founder
Stock Details
Investors List
Inventages Venture Capital Investment Inc.
Inventages Venture Capital Investment Inc. investment in Series A - Shield Therapeutics
Official Site Inspections
http://www.shieldtherapeutics.com
- Host name: 167.99.200.154
- IP address: 167.99.200.154
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1